Nagalase is an enzyme produced by cancer cells and certain viruses, including HIV, influenza, and some parasites. This enzyme is harmful to the immune system because it breaks down an essential protein called Gc-protein. Gc-protein is the precursor to GcMAF (Gc-protein-derived macrophage activating factor), a powerful immune stimulator. GcMAF activates macrophages, the white blood cells responsible for destroying infected and cancerous cells.
By degrading Gc-protein, Nagalase prevents the body from producing GcMAF. This suppresses immune function, leaving cancer and viral infections free to progress.
In short, Nagalase blocks one of the body’s key immune defense pathways.
For more information, contact: enquiries@www.dubaibioremedix.com
The Benefits of Nagalase Testing:
Nagalase testing provides valuable insight into the health of the immune system. It has many important uses in both diagnosis and monitoring of cancer and viral infections:
Early detection of cancer: Nagalase can be detected at earlier stages than traditional methods such as biopsies, CT, or MRI scans, which are often invasive, expensive, or risky.
Monitoring treatment progress: Nagalase levels fall quickly after effective treatments, such as surgery, chemotherapy, radiotherapy, or immunotherapy. This makes it a highly effective marker for measuring the success of therapy.
Personalizing immunotherapy: Testing helps guide the optimal dose and duration of GcMAF/VDTP (Vitamin D Binding Protein-derived Therapy), while also evaluating its safety and effectiveness.
Historically, Nagalase testing had limitations, with accuracy rates around 60 percent, and availability was restricted until now.
A Breakthrough: Rapid Nagalase Test Kits
www.dubaibioremedix.com has developed a new generation of Nagalase rapid test kits that are changing the landscape of cancer and immune system monitoring.
Highly accurate: 98 percent accuracy.
Fast results: Less than 10 minutes.
Convenient: Can be used at home, in clinics, and in hospitals.
These kits use a small blood sample and a proprietary two-step immunocapture assay to measure Nagalase activity. They can detect even very low levels of the enzyme and differentiate between:
Free Nagalase (active enzyme)
Bound Nagalase (inactive enzyme)
Total Nagalase (free plus bound)
This breakthrough makes it possible for patients to test themselves and track their recovery, giving them greater control over their health.
Why This Matters:
Early cancer detection improves survival rates.
Monitoring for tumor recurrence or metastasis helps patients and doctors act quickly.
Guiding immunotherapy such as VDTP ensures precision treatment tailored to each patient.
Accessible for everyone: These tests are useful not only for patients but also for healthy individuals who wish to check the performance of their immune system. Nagalase testing can serve as a proactive health check, offering peace of mind and early warning of hidden disease.
Overcoming Past Limitations:
Traditional Nagalase testing involved sending blood samples to specialized labs, centrifuging, and waiting weeks or even months for results. Accuracy was limited, and availability was scarce.
The new rapid test kits from www.dubaibioremedix.com eliminate these problems. They provide immediate, reliable results without the delays or complications of traditional testing.
Conclusion:
www.dubaibioremedix.com has validated these rapid Nagalase kits with global clinical research. Standardized reference ranges have been established, and the tests have been shown to be cost-effective, practical, and reliable.
For the first time, accurate Nagalase testing is affordable and available worldwide for use at home, in clinics, laboratories, and hospitals.
Ask your practitioner to stock these tests if they do not already.
For more details, visit:
https://www.dubaibioremedix.com/.../naga-nagalase-test-kit/
Feel free to join our GcMAF Scientific Information Research Facebook group. https://www.facebook.com/groups/2053703715028393/
Written by Maryjayne Aria
